Erik H.J. Hulzebos

3.8k total citations
76 papers, 2.4k citations indexed

About

Erik H.J. Hulzebos is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Erik H.J. Hulzebos has authored 76 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 25 papers in Cardiology and Cardiovascular Medicine and 16 papers in Complementary and alternative medicine. Recurrent topics in Erik H.J. Hulzebos's work include Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers), Cystic Fibrosis Research Advances (16 papers) and Cardiovascular and exercise physiology (16 papers). Erik H.J. Hulzebos is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers), Cystic Fibrosis Research Advances (16 papers) and Cardiovascular and exercise physiology (16 papers). Erik H.J. Hulzebos collaborates with scholars based in Netherlands, United States and United Kingdom. Erik H.J. Hulzebos's co-authors include Tim Takken, Paul J.M. Helders, N.L.U. van Meeteren, Rob A. de Bie, Marco van Brussel, Aart Brutel de la Rivière, Bart C. Bongers, Thomas J. Hoogeboom, Jaap J. Dronkers and Yolba Smit and has published in prestigious journals such as JAMA, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Erik H.J. Hulzebos

73 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik H.J. Hulzebos Netherlands 26 998 970 586 357 329 76 2.4k
Sue Jenkins Australia 30 2.1k 2.1× 519 0.5× 167 0.3× 607 1.7× 595 1.8× 91 2.9k
Brian Carlin United States 20 2.2k 2.2× 371 0.4× 237 0.4× 408 1.1× 326 1.0× 76 2.6k
Penelope J. Thompson Canada 6 876 0.9× 1.0k 1.1× 353 0.6× 375 1.1× 673 2.0× 6 2.8k
P Weiner Israel 33 1.8k 1.8× 410 0.4× 309 0.5× 947 2.7× 382 1.2× 92 2.7k
Irene Steenbruggen Netherlands 10 2.3k 2.3× 215 0.2× 203 0.3× 994 2.8× 137 0.4× 17 3.0k
Luíz Eduardo Nery Brazil 30 2.6k 2.6× 954 1.0× 302 0.5× 1.2k 3.5× 1.3k 3.8× 126 4.0k
Vítor Oliveira Carvalho Brazil 27 239 0.2× 940 1.0× 231 0.4× 248 0.7× 650 2.0× 103 2.1k
Luís Puente‐Maestu Spain 29 2.5k 2.5× 601 0.6× 175 0.3× 977 2.7× 853 2.6× 134 3.3k
Jordi Vilaró Spain 28 1.7k 1.7× 333 0.3× 87 0.1× 593 1.7× 504 1.5× 92 2.7k
Hülya Arıkan Türkiye 21 794 0.8× 315 0.3× 117 0.2× 397 1.1× 243 0.7× 106 1.9k

Countries citing papers authored by Erik H.J. Hulzebos

Since Specialization
Citations

This map shows the geographic impact of Erik H.J. Hulzebos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik H.J. Hulzebos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik H.J. Hulzebos more than expected).

Fields of papers citing papers by Erik H.J. Hulzebos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik H.J. Hulzebos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik H.J. Hulzebos. The network helps show where Erik H.J. Hulzebos may publish in the future.

Co-authorship network of co-authors of Erik H.J. Hulzebos

This figure shows the co-authorship network connecting the top 25 collaborators of Erik H.J. Hulzebos. A scholar is included among the top collaborators of Erik H.J. Hulzebos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik H.J. Hulzebos. Erik H.J. Hulzebos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Takken, Tim, et al.. (2025). An update on clinical recommendations for cardiopulmonary exercise testing in children with respiratory diseases. Expert Review of Respiratory Medicine. 20(2). 133–147.
3.
Veldhoen, Esther S., Roelie M. Wösten‐van Asperen, Michael A. Gaytant, et al.. (2023). Evidence for Beneficial Effect of Daily Use of Mechanical Insufflation-Exsufflation in Patients With Neuromuscular Diseases. Respiratory Care. 68(4). 531–546. 5 indexed citations
4.
Bartels, Bart, Fay‐Lynn Asselman, Esther S. Veldhoen, et al.. (2023). The RESISTANT study (Respiratory Muscle Training in Patients with Spinal Muscular Atrophy): study protocol for a randomized controlled trial. BMC Neurology. 23(1). 118–118. 1 indexed citations
5.
Takken, Tim & Erik H.J. Hulzebos. (2023). Practical Aspects of Cardiopulmonary Exercise Testing in Children. International Journal of Sports Medicine. 45(6). 403–410. 4 indexed citations
6.
Slieker, Martijn G., et al.. (2022). Is Measuring Physical Literacy in School-Aged Children With Cystic Fibrosis or Congenital Heart Disease Needed?. Pediatric Physical Therapy. 35(1). 43–47. 4 indexed citations
7.
Takken, Tim, et al.. (2019). Exercise responses in children and adults with a Fontan circulation at simulated altitude. Congenital Heart Disease. 14(6). 1005–1012. 11 indexed citations
8.
Hulzebos, Erik H.J., et al.. (2018). Reference values for maximum work rate in apparently healthy Dutch/Flemish adults: data from the LowLands fitness registry. Acta cardiologica. Supplementum. 74(3). 223–230. 20 indexed citations
9.
Leiner, Tim, Gertjan T. Sieswerda, Arie P.J. van Dijk, et al.. (2018). RV adaptation to increased afterload in congenital heart disease and pulmonary hypertension. PLoS ONE. 13(10). e0205196–e0205196. 10 indexed citations
10.
Hebestreit, Helge, Erik H.J. Hulzebos, Jane E. Schneiderman, et al.. (2018). Cardiopulmonary Exercise Testing Provides Additional Prognostic Information in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 199(8). 987–995. 91 indexed citations
11.
Sieswerda, Gertjan T., Pieter A. Doevendans, Erik H.J. Hulzebos, et al.. (2018). Tricuspid flow and regurgitation in congenital heart disease and pulmonary hypertension: comparison of 4D flow cardiovascular magnetic resonance and echocardiography. Journal of Cardiovascular Magnetic Resonance. 20(1). 5–5. 40 indexed citations
12.
Bongers, Bart C., Jaap Dronkers, Erik H.J. Hulzebos, et al.. (2016). Optimizing perioperative physical therapy care in major elective surgery to improve surgical outcome in high-risk patients: the Better in, Better out™ concept.. Data Archiving and Networked Services (DANS). 29(6). 134–139. 6 indexed citations
13.
Hebestreit, Helge, Hubertus G.M. Arets, Paul Aurora, et al.. (2015). Statement on Exercise Testing in Cystic Fibrosis. Respiration. 90(4). 332–351. 120 indexed citations
14.
Bongers, Bart C., Marco van Brussel, Erik H.J. Hulzebos, & Tim Takken. (2014). Pediatric norms for cardiopulmonary exercise testing In relation to sex and age. Data Archiving and Networked Services (DANS). 32 indexed citations
15.
Beekman, Emmylou, Ilse Mesters, Nanné K. de Vries, et al.. (2011). Therapeutic Consequences for Physical Therapy of Comorbidity Highly Prevalent in COPD: A Multi-case Study. Journal of Allergy & Therapy. s2.
16.
Brussel, Marco van, Janjaap van der Net, Erik H.J. Hulzebos, Paul J.M. Helders, & Tim Takken. (2011). The Utrecht Approach to Exercise in Chronic Childhood Conditions. Pediatric Physical Therapy. 23(1). 2–14. 81 indexed citations
17.
Takken, Tim, A. Christian Blank, Erik H.J. Hulzebos, et al.. (2009). Cardiopulmonary exercise testing in congenital heart disease: (contra)indications and interpretation. Netherlands Heart Journal. 17(10). 385–392. 51 indexed citations
18.
Takken, Tim, A. Christian Blank, Erik H.J. Hulzebos, et al.. (2009). Cardiopulmonary exercise testing in congenital heart disease: equipment and test protocols. Netherlands Heart Journal. 17(9). 339–344. 43 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sue Jenkins Breakdown of academic impact, for papers by Brian Carlin Breakdown of academic impact, for papers by Penelope J. Thompson Breakdown of academic impact, for papers by P Weiner Breakdown of academic impact, for papers by Irene Steenbruggen Breakdown of academic impact, for papers by Luíz Eduardo Nery Breakdown of academic impact, for papers by Vítor Oliveira Carvalho Breakdown of academic impact, for papers by Luís Puente‐Maestu Breakdown of academic impact, for papers by Jordi Vilaró Breakdown of academic impact, for papers by Hülya Arıkan
Rankless by CCL
2026